US FDA sets its sights on delta-8 THC, firing warnings over health claims

The US Food and Drug Administration (FDA) has sent warning letters to five marketers of delta-8 THC products based on health claims the companies made.

The letters are the first sent by the FDA on delta-8 products. However, they largely mirror ones previously sent to companies that made health claims about CBD – indeed several of the companies involved were also warned about CBD claims.

And although health claims appear to be what triggered the warnings, the FDA took a much larger swipe at delta-8 products generally.